Precision radiation aims to shrink prostate cancer with fewer side effects
NCT ID NCT07644598
First seen Jun 12, 2026 · Last updated Jun 22, 2026 · Updated 2 times
Summary
This study tests a new way to give radiation for low to intermediate risk prostate cancer. Using MRI scans, doctors will deliver a higher radiation dose to the tumor while lowering the dose to the rest of the prostate. The goal is to control the cancer while reducing side effects. About 58 men will take part and be followed for up to 5 years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALIZED PROSTATE CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Lombardi Comprehensive Cancer Center, Georgetown University
Washington D.C., District of Columbia, 20007, United States
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
radiation therapy (SBRT with microboost)
What this could lead to
If successful, this could offer a more precise, safer radiation treatment for early-stage prostate cancer, reducing side effects while controlling the disease.
What could go wrong
This is a small, early-phase trial (58 people) testing safety and side effects, not yet proven to work better than standard treatments. There is still a risk of urinary or bowel side effects from radiation.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.